MedPGx Email Formats

Insurance • San Diego, California, United States • 1-10 Employees

Key Contact at MedPGx

Dale Brown

Chief Executive Officer & Co-Founder

Company overview

Headquarters	San Diego, California, United States
Websites	medpgx.com medivix.ai
NAICS	52
Keywords	Personalized Medicine, Genetic Testing, Pharmacies, Lab Testing, Pharmacogenomic Testing, Medication Therapy Management, Precision Diagnostics, Adverse Drug Reaction Management
Founded	2022
Employees	1-10

About MedPGx

About Founded in 2022 by PBM veterans, MedPGx provides the first specialized Precision Diagnostics Marketplace that integrates consumer, payer, and provider functionality to facilitate the use of precision diagnostics to improve pharmacy care both clinically and financially. MedPGx Menu of Services The MedPGx platform provides pharmacists, and consumers access to a menu of pharmacogenomic and other diagnostics to order tests and review results online. The MedPGx menu of services is supported by a network of laboratories that compete on quality, service, and price for their tests. MedPGx itself is not a lab and does not perform testing. Industry Standards MedPGx is committed to working with NCPDP and other industry stakeholders to establish industry standards for the use of pharmacogenomics and other diagnostics. Benefits of adopting PGx testing: Personalize and optimize medication plans for patients based on their genetic makeup Improve safety and efficacy for patients. Reduce trial and error and adverse drug reactions Lower healthcare costs associated with ineffective treatments and adverse reactions Increase patient loyalty. Boost pharmacy revenues. The Role of the Pharmacist At MedPGx, we believe in empowering pharmacists to take on a more prominent role in precision medicine by seamlessly integrating pharmacogenetics testing into their practices. By doing so, we aim to improve patient access, safety, and clinical outcomes while increasing customer loyalty and pharmacy profitability through testing and medication therapy management (MTM). Relevant PGx Statistics Over 90% of people carry at least one drug-reactive gene variant. 82% of Americans take at least one medication. 65% of people are exposed to a PGx-relevant drug. 50% of medications taken are ineffective, according to the FDA. Adverse drug reactions (ADRs) are the fourth to the sixth leading cause of death worldwide. Pharmacogenetics testing reduced hospitalization by 52% among patients.